Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager

Ascendis Pharma A/S

NASDAQ:ASND

Watchlist

Dividends

Price: 124.33 USD -1.75% Market Closed

Market Cap: 7.1B USD

Have any thoughts about
Ascendis Pharma A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 124.33 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ASND Alert

Ascendis Pharma A/S

124.33

-2.22 (-1.75%)

52 Week Range	89.43 159.4
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Ascendis Pharma A/S

What unique competitive advantages
does Ascendis Pharma A/S hold over its rivals?

What risks and challenges
does Ascendis Pharma A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Ascendis Pharma A/S.

What unique competitive advantages
does Ascendis Pharma A/S hold over its rivals?

What risks and challenges
does Ascendis Pharma A/S face in the near future?

Summarize the latest earnings call
of Ascendis Pharma A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ascendis Pharma A/S.

Provide P/S
for Ascendis Pharma A/S.

Provide P/E
for Ascendis Pharma A/S.

Provide P/OCF
for Ascendis Pharma A/S.

Provide P/FCFE
for Ascendis Pharma A/S.

Provide P/B
for Ascendis Pharma A/S.

Provide EV/S
for Ascendis Pharma A/S.

Provide EV/GP
for Ascendis Pharma A/S.

Provide EV/EBITDA
for Ascendis Pharma A/S.

Provide EV/EBIT
for Ascendis Pharma A/S.

Provide EV/OCF
for Ascendis Pharma A/S.

Provide EV/FCFF
for Ascendis Pharma A/S.

Provide EV/IC
for Ascendis Pharma A/S.

Show me price targets
for Ascendis Pharma A/S made by professional analysts.

What are the Revenue projections
for Ascendis Pharma A/S?

How accurate were the past Revenue estimates
for Ascendis Pharma A/S?

What are the Net Income projections
for Ascendis Pharma A/S?

How accurate were the past Net Income estimates
for Ascendis Pharma A/S?

What are the EPS projections
for Ascendis Pharma A/S?

How accurate were the past EPS estimates
for Ascendis Pharma A/S?

What are the EBIT projections
for Ascendis Pharma A/S?

How accurate were the past EBIT estimates
for Ascendis Pharma A/S?

Compare the revenue forecasts
for Ascendis Pharma A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ascendis Pharma A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ascendis Pharma A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ascendis Pharma A/S compared to its peers.

Compare the P/E ratios
of Ascendis Pharma A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Ascendis Pharma A/S with its peers.

Analyze the financial leverage
of Ascendis Pharma A/S compared to its main competitors.

Show all profitability ratios
for Ascendis Pharma A/S.

Provide ROE
for Ascendis Pharma A/S.

Provide ROA
for Ascendis Pharma A/S.

Provide ROIC
for Ascendis Pharma A/S.

Provide ROCE
for Ascendis Pharma A/S.

Provide Gross Margin
for Ascendis Pharma A/S.

Provide Operating Margin
for Ascendis Pharma A/S.

Provide Net Margin
for Ascendis Pharma A/S.

Provide FCF Margin
for Ascendis Pharma A/S.

Show all solvency ratios
for Ascendis Pharma A/S.

Provide D/E Ratio
for Ascendis Pharma A/S.

Provide D/A Ratio
for Ascendis Pharma A/S.

Provide Interest Coverage Ratio
for Ascendis Pharma A/S.

Provide Altman Z-Score Ratio
for Ascendis Pharma A/S.

Provide Quick Ratio
for Ascendis Pharma A/S.

Provide Current Ratio
for Ascendis Pharma A/S.

Provide Cash Ratio
for Ascendis Pharma A/S.

What is the historical Revenue growth
over the last 5 years for Ascendis Pharma A/S?

What is the historical Net Income growth
over the last 5 years for Ascendis Pharma A/S?

What is the current Free Cash Flow
of Ascendis Pharma A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ascendis Pharma A/S.

ASND

Income Statement

Interest Income Expense

Ascendis Pharma A/S
Interest Income Expense

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Ascendis Pharma A/S
Interest Income Expense Peer Comparison

Comparables:

GMAB

ZEAL

BAVA

FLUO

BIOPOR

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company		Interest Income Expense	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Ascendis Pharma A/S NASDAQ:ASND	Interest Income Expense -€126.9m	CAGR 3-Years -45%	CAGR 5-Years N/A	CAGR 10-Years -73%
	Genmab A/S CSE:GMAB	Interest Income Expense kr1.6B	CAGR 3-Years 643%	CAGR 5-Years 53%	CAGR 10-Years 65%
	Zealand Pharma A/S CSE:ZEAL	Interest Income Expense kr119.1m	CAGR 3-Years N/A	CAGR 5-Years 36%	CAGR 10-Years 45%
B	Bavarian Nordic A/S CSE:BAVA	Interest Income Expense kr93.2m	CAGR 3-Years N/A	CAGR 5-Years 56%	CAGR 10-Years N/A
F	Fluoguide AS STO:FLUO	Interest Income Expense kr47k	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Bioporto A/S CSE:BIOPOR	Interest Income Expense kr558k	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A

What is Ascendis Pharma A/S's Interest Income Expense?

Interest Income Expense
-126.9m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Interest Income Expense amounts to -126.9m EUR.

What is Ascendis Pharma A/S's Interest Income Expense growth rate?

Interest Income Expense CAGR 10Y
-73%

Over the last year, the Interest Income Expense growth was -384%. The average annual Interest Income Expense growth rates for Ascendis Pharma A/S have been -45% over the past three years , and -73% over the past ten years .

Ascendis Pharma A/S
NASDAQ:ASND

Ascendis Pharma A/S
Interest Income Expense

Ascendis Pharma A/S
Interest Income Expense Peer Comparison

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

See Also

What is Ascendis Pharma A/S's Interest Income Expense?

Interest Income Expense
-126.9m EUR

What is Ascendis Pharma A/S's Interest Income Expense growth rate?

Interest Income Expense CAGR 10Y
-73%

Company

Help

Tools

Stocks

Ascendis Pharma A/S NASDAQ:ASND

Ascendis Pharma A/S Interest Income Expense

Ascendis Pharma A/S Interest Income Expense Peer Comparison

Competitive Interest Income Expense Analysis Latest Figures & CAGR of Competitors

See Also

What is Ascendis Pharma A/S's Interest Income Expense? Interest Income Expense -126.9m EUR

What is Ascendis Pharma A/S's Interest Income Expense growth rate? Interest Income Expense CAGR 10Y -73%

Company

Help

Tools

Stocks

Ascendis Pharma A/S
NASDAQ:ASND

Ascendis Pharma A/S
Interest Income Expense

Ascendis Pharma A/S
Interest Income Expense Peer Comparison

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

What is Ascendis Pharma A/S's Interest Income Expense?

Interest Income Expense
-126.9m EUR

What is Ascendis Pharma A/S's Interest Income Expense growth rate?

Interest Income Expense CAGR 10Y
-73%